1. Introduction {#s0025}
===============

Individual characteristics affect the immune response to infectious diseases [@bb0005] and vaccines [@bb0010]. Sex differences in the incidence of infectious diseases have long been recognized [@bb0015], [@bb0020]. The study of sex differences in infectious diseases can provide keys to the mechanism of infection and lead to improved treatment and vaccine development. Recently, Poland et al. [@bb0010] pointed out that gaps in understanding how vaccines stimulate an immune response has inhibited our understanding of the variability in the responses of individuals and sub-groups.

Viral meningitis can result from a number of infections such as enteroviruses, Herpes simplex, West Nile virus, mumps, and measles. In children in highly vaccinated communities, infection is usually attributed to enteroviruses such as Coxsackie, ECHO, and enterovirus 71 [@bb0025], [@bb0030], [@bb0035], [@bb0040]. In such cases, the transmission is usually feco--oral and occurs mainly in the summer and autumn months in temperate climates. In isolated reports, the incidence rates of viral meningitis have been reported to be higher in males [@bb0015], [@bb0045], [@bb0050]. However, the subject has not been rigorously evaluated and the reports on sex differences in the incidence rates are usually based on single data sources from individual countries and for varying age groups [@bb0015], [@bb0045], [@bb0050]. The possible mechanism underlying this sex difference is not clear. Behavioral differences may play a part, although that seems unlikely in very young children. X chromosome related sex differences in immunodeficiency could also play a role [@bb0055], [@bb0060] and sex hormones may be important [@bb0065].The aim of this study was to evaluate the magnitude and consistency of the sex differences in the incidence rates of viral meningitis at different ages, in different countries, and over a number of years.

Research in context*Evidence Before This Study*The importance of evaluating sex differences in disease is an increasing area of interest in the understanding of the mechanisms of disease. Sex differences in the incidence rates for viral meningitis have been reported from studies in single countries and over defined time periods. It is not clear to what extent these differences vary by age and are consistent over countries and over time.*Added Value of This Study*To the best of our knowledge, this is the first comprehensive study of magnitude of the sex differences in the incidence rates for viral meningitis at different ages for a number of countries over different time periods. Our study provides stable estimates of the extent of the excess male incidence rates in viral meningitis in infants and children up to age 15.*Implications of All The Available Evidence*Our findings should stimulate investigations on sex-related factors impacting on the clinical manifestation of viral meningitis, which can have important implications for targeted treatment and the development and dose schedules of current and new vaccines.Alt-text: Unlabelled Box

2. Methods {#s0030}
==========

2.1. Search Strategy {#s0035}
--------------------

We restricted our analyses to published national data on viral meningitis incidence rates by age and sex. Published studies based on hospital or local data, usually do not have population denominators, and thus age and sex specific incidence rates cannot be calculated. This could be an important source of selection bias. We identified five countries with reliable reporting and diagnostic systems for which published national data by age, sex and year were available. In most of the databases, the actually causative organism is not specified and is generalized for all causes of viral meningitis. The surveillance and the methods of viral meningitis diagnosis may not be identical over countries and time, but are unlikely to differ between males and females.

2.2. Sources of Data {#s0040}
--------------------

For Canada, data were available from the Public Health Agency of Canada, for the period 1991 to 1999 (latest available data) [@bb0070]. For the Czech Republic, data for the years 2008--2013 were obtained from the Institute of Health Information and Statistics [@bb0075]. For Germany, data for the years 2000--2015, were obtained from the German Federal Health Monitoring System [@bb0080]. In Israel, data were available for 2001--2016, from the archives of the Department of Epidemiology in the Ministry of Health. For Poland, data for the years 2006--2016 were obtained from the National Institute of Public Health [@bb0085]. Information on the population size by age, sex and year was obtained via the official web site of each country - for Canada, from the Statistics, CANSIM database [@bb0090], for the Czech Republic from the Czech Statistical Office [@bb0095], for Germany, from the German Federal Health Monitoring System [@bb0100], for Israel from the Central Bureau of Statistics [@bb0105], and for Poland from official web site Statistics Poland [@bb0110].

2.3. Ethics {#s0045}
-----------

Since, national, open access, aggregative and anonymous data were used, there was no need for ethics committee approval.

2.4. Statistical analyses {#s0050}
-------------------------

### 2.4.1. Calculation of incidence rates {#s0055}

We calculated viral meningitis incidence rates (IR) by sex and age group, for each country and calendar year. Incidence rates per 100,000 were calculated as the number of reported cases divided by the respective population size and multiplied by 100,000. The age groups considered were \< 1 (infants), 1--4 (early childhood), 5--9 (late childhood), 10--14 (puberty), 15--44 (young adulthood), and 45--64 (middle adulthood) years. The Canadian surveillance system used similar age-groups except for the ages 15--39 and 40--59. The male:female incidence rate ratio (RR) was calculated by dividing the incidence rate in males by that of females.

2.5. Meta-analyses {#s0060}
------------------

We performed the statistical analyses using meta-analysis methodology where country and calendar year within each age group were considered as "studies". The outcome variable was the male:female incidence RR. We combined the incidence RR\'s using the meta--analysis package in Stata version 12.1 (Stata Corp., College Station, TX), separately for each age group, by country and time period (years). Pooled incidence RRs were obtained for each age group, combining countries and calendar years. The results are presented in forest plots. Heterogeneity was evaluated using Cochran\'s Q statistic. Tau^2^ and I^2^ were used to estimate the between-study variance [@bb0115]. If I^2^ ≥ 50% and/or the Q test yielded a p-value \< 0.1, the random effects model (DerSimonian and Laird) was used to estimate pooled RRs and 95% confidence intervals (CI). Otherwise the fixed effects model was used.

2.6. Sensitivity analyses {#s0065}
-------------------------

To evaluate the effect of individual county on the pooled male:female incidence RR\'s, we performed leave-one-out sensitivity analysis and recomputed the pooled RRs for each age group separately.

2.7. Meta-regression analyses {#s0070}
-----------------------------

In order to explore the main sources of variation in the incidence RRs, meta-regression analyses were performed including age-group, country and time periods as the possible explanatory variables.

2.8. Asymmetry analysis {#s0075}
-----------------------

We explored possible differences in the impact of selected countries or time periods using funnel plots with visual inspection and the Egger test for asymmetry.

3. Results {#s0080}
==========

The summary of male and female incidence rates (per 100,000 populations) in different countries for each age group is presented in [Table 1](#tbl0005){ref-type="table"}. In every country (Czech Republic data is missing for age \< 1) the incidence rate of viral meningitis was higher in males compared to females at ages \< 1, 1--4, 5--9 and 10--14. Viral meningitis incidence rates tend to decline with age.Table 1Details of the countries included in the meta-analysis, by sex and age group - descriptive data (IR per 100,000 male or female population). IR = incidence ratio.Table 1MalesFemalesAge groupCountryYearsn/NIRn/NIR females\< 1Canada1991--1999342/173702819.7260/165018015.8Czech Republic2008--2013No dataNo dataNo dataNo dataGermany2000--20151466/574202025.5997/544915618.3Israel2001--2016546/128460042.5362/121960029.7Poland2006--201644/21775232.031/20557641.51--4Canada1991--1999134/72481361.884/69036561.2Czech Republic2008--201367/14107484.753/13436703.9Germany2000--20154010/23640633171904/224381138.5Israel2001--2016382/49653007.7192/47173004.1Poland2006--2016339/87638103.9183/82940522.25--9Canada1991--1999307/92042303.3168/87668071.9Czech Republic2008--2013261/153266917138/14506219.5Germany2000--20158155/3104995926.33846/2946753913.1Israel2001--2016380/57273006.6193/54429003.5Poland2006--2016937/107532788.7468/102065014.610--14Canada1991--1999216/91666332.4141/86964551.6Czech Republic2008--2013313/141600122.1145/133951810.8Germany2000--20153972/3398456211.72496/322370087.7Israel2001--2016119/52528002.381/49954001.6Poland2006--2016954/111301778.6506/105919514.815--44Canada [@bb0075], [@bb0080], [@bb0085], [@bb0090], [@bb0095], [@bb0100], [@bb0105], [@bb0110], [@bb0115], [@bb0120], [@bb0125], [@bb0130], [@bb0135], [@bb0140], [@bb0145], [@bb0150], [@bb0155], [@bb0160], [@bb0165], [@bb0170], [@bb0175], [@bb0180], [@bb0185], [@bb0190], [@bb0195]1991--1999549/517679831.1581/504525451.2Czech Republic2008--2013987/137258187.2837/129789126.4Germany2000--201523,505/260599725923,949/2502381979.6Israel2001--2016386/255426001.5343/252393001.4Poland2006--20163649/928022393.93177/900973523.545--64Canada (40--59)1991--199976/326682960.299/327894220.3Czech Republic2008--2013202/84037292.4238/86248802.8Germany2000--20155829/1799378463.26057/1801196913.4Israel2001--201625/108220000.245/116448000.4Poland2006--20161039/551278621.91050/591806781.8

3.1. Pooled incidence RRs and forest plots {#s0085}
------------------------------------------

The forest plot for infants (age 0--1) is shown in [Fig. 1](#fig0005){ref-type="fig"}. The overall pooled incidence RR was 1.38 (95% CI 1.30--1.47), indicating a 38% higher incidence of disease in males. By country, the pooled incidence RRs varied from 1.25 in Canada to 1.43 in Israel. Heterogeneity was low with I^2^ = 15.8%, and Tau^2^ = 0.0103. The forest plot for early childhood (ages 1--4) is shown in [Fig. 2](#fig0010){ref-type="fig"}. The overall pooled incidence RR was1.94 (95% CI 1.85--2.03) indicating a 94% excess in incidence rates in males. By country the pooled incidence RRs varied from 1.20 for the Czech population to 2.0 for Germany with I^2^ = 10.1%, and Tau^2^ = 0.0042. The forest plot for late childhood [@bb0025], [@bb0030], [@bb0035], [@bb0040], [@bb0045] is shown in [Fig. 3](#fig0015){ref-type="fig"}. The overall pooled RR was 1.98 (95% CI 1.88--2.07), indicating a 98% excess in males, and the pooled incidence RRs varied between Canada, incidence RR = 1.72 to Germany with incidence RR = 2.05. Heterogeneity was mild I^2^ = 30.6%, and Tau^2^ = 0.0082. The forest plot for puberty [@bb0050], [@bb0055], [@bb0060], [@bb0065], [@bb0070] is shown in [Fig. 4](#fig0020){ref-type="fig"}. The overall pooled incidence RR was 1.58 (95% CI 1.47--1.71), indicating a 58% excess in males with I^2^ = 51.6%, and Tau^2^ = 0.0307. The pooled incidence RRs varied between 1.35 for Israel to 2.0 for the Czech Republic. The forest plots for young adults (15--44 or 15--39 years) and middle-age adults (45--64 or 40--59 years) are shown in Appendix A. For young adults (Fig. A1), there was no significant difference in incidence rates between males and females (overall incidence RR = 1.00, 95% CI 0.97--1.03, I^2^ = 60.2%, and Tau^2^ = 0.0063). Female predominance is significant only for the German population (incidence RR = 0.94). For middle-age adults (Fig. A2), females had borderline higher incidence rates compared with males (overall incidence RR = 0.97, 95% CI 0.94--1.00, I^2^ = 6.9%, and Tau^2^ = 0.0012). Although meta-analysis results by age groups showed the highest heterogeneity in Germany, the incidence rates over the time period were consistently higher in males.Fig. 1Forest plot of the male to female viral meningitis incidence rate ratios (RR) for different years in Canada, Germany, Israel, and Poland in infants (\< 1 years). (The shading indicates the weight of the study in the analysis). CI = confidence interval. RR = rate ratio.Fig. 1Fig. 2Forest plot of the male to female viral meningitis incidence rate ratios (RR) for different years in Canada, Czech Republic, Germany, Israel, and Poland in early childhood (ages 1--4). (The shading indicates the weight of the study in the analysis). CI = confidence interval. RR = rate ratio.Fig. 2Fig. 3Forest plot of the male to female viral meningitis incidence rate ratios (RR) for different years in Canada, Czech Republic, Germany, Israel, and Poland in late childhood (ages 5--9). (The shading indicates the weight of the study in the analysis). CI = confidence interval. RR = rate ratio.Fig. 3Fig. 4Forest plot of the male to female viral meningitis incidence rate ratios (RR) for different years in Canada, Czech Republic, Germany, Israel, and Poland in puberty (ages 10--14). (The shading indicates the weight of the study in the analysis). CI = confidence interval. RR = rate ratio.Fig. 4

3.2. Sensitivity analysis {#s0090}
-------------------------

To evaluate the effect of individual county on the pooled RR, we performed leave-one-out sensitivity analysis and recomputed the pooled RRs (are represented in [Table 2](#tbl0010){ref-type="table"}). After omitting each country (one country at a time), the pooled incidence RR\'s remained very similar. Thus, no single country substantially affected the pooled incidence RRs. This confirms that the results of this meta-analysis are stable and robust.Table 2Sensitivity analysis, by age group and removing one country at a time. (RR = rate ratio; CI = confidence interval).Table 2RR\'s (CI) for one country removedCountry removedAge group\< 11--45--910--1415--44\
(15--39 for Canada)45--64\
(40--59 for Canada)Canada1.40\
(1.31--1.50)1.95\
(1.86--2.05)2.00\
(1.92--2.06)1.68\
(1.44--1.94)1.06\
(0.94--1.19)0.97\
(0.94--1.004)Czech Republic--1.95\
(1.86--2.05)1.99\
(1.92--2.06)1.57\
(1.40--1.76)1.02\
(0.91--1.14)0.97\
(0.94--1.004)Germany1.35\
(1.23--1.50)1.71\
(1.53--1.53)1.85\
(1.71--2.00)1.69\
(1.45--1.97)1.07\
(0.99--1.16)0.99\
(0.92--1.07)Israel1.36\
(1.27--1.47)1.94\
(1.85--2.04)1.98\
(1.92--2.06)1.67\
(1.45--1.92)1.02\
(0.91--1.14)0.97\
(0.94--1.003)Poland1.38\
(1.30--1.47)1.95\
(1.86--2.05)1.99\
(1.92--2.06)1.59\
(1.37--1.84)1.01\
(0.91--1.12)0.95\
(0.92--0.99)

3.3. Asymmetry analysis {#s0095}
-----------------------

Egger\'s test was not significant for infants, in late childhood, puberty and middle adulthood suggesting no asymmetry in the findings (Egger test for asymmetry p = 0.618, p = 0.716, p = 0.873, p = 0.102 respectively). Some evidence of asymmetry was observed for the early childhood (p = 0.016) and young adulthood (p = 0.010). Data are presented in Appendix B, Fig. B1 (A--F).

3.4. Meta-regression analysis {#s0100}
-----------------------------

Meta-regression results revealed that age group (p \< 0.0001) contributed almost all the source of heterogeneity (for country p = 0.292 and for reported year p = 0.294). In the age-groups, there was no significant difference between the infancy and puberty, early and late childhood and between young and middle adulthood (p \> 0.05). The heterogeneity for Germany resulted from differences in the sex ratio from year to year. However, the male to female ratio was consistently greater than unity, and the heterogeneity over time is likely to be due to random variation. The heterogeneity in late childhood, puberty and young adulthood resulted are alos likely to be due at least partly from random variation in the sex ratios from year to year and country to country.

4. Discussion {#s0105}
=============

Using national data on viral meningitis from five countries, over a period of 6--16 years, we used meta-analyses and meta-regression to evaluate the male to female, incidence rate ratios by age group. Our analyses revealed that the incidence rates were 38%, 94%, 98% and 58% higher in males in infancy, young and late childhood and puberty, respectively. The findings are remarkably consistent over countries and over a number of years. In young and older adults, there were no significant sex differences. We believe that the current study is the first to provide stable estimates of the excess male incidence rates for specific age groups from a number of countries in diverse geographic regions and over extended time periods.

In general, the excess male incidence rates for viral meningitis that we have demonstrated, using data with reliable, national denominators, considerably strengthen the findings reported from hospital-based studies in single countries, at specific time periods. For example, in the British Pediatric Surveillance Unit (BPSU) system, over an 18-month period, there was an excess of 20% in male incidence rates in newborn babies [@bb0120], and in a cohort study in Denmark between 1977 and 2001, the incidence rate was higher in males in the first 6 months of life [@bb0050]. In China, a multicenter prospective study of viral meningitis at five hospitals from 2009 to 2012 revealed a male to female incidence ratio of 2.24 in children with a mean age of 6.4 years [@bb0125]. In a retrospective cohort study in Spain [@bb0045] there was male predominance among children with a mean age of 5.9 years. In Poland, between 2011 and 2014,the male to female ratio of viral meningitis rates in children aged 5--9 years was 1.77 [@bb0130]. In Germany, the male to female incidence rate ratios for non-polio enteroviruses meningitis ratios were 2.8 at ages 6.8 ± 3.8 years and 2.0 at ages 7.1 ± 4.1 [@bb0135].

For Israel between 1971 and 1985, the average male to female incidence rate ratio was 2.0 for children under the age of 10 [@bb0015]. In addition, in children aged under 4 years, a higher incidence among males was observed for viral hepatitis, shigellosis, and salmonellosis [@bb0015]. Our study cannot provide clues to mechanisms. However, we can speculate on mechanism. As we mentioned earlier, the countries in the study do not have a culture of differentiating between the sexes in providing health care to infants and children. There may be sex differences in adults in the use of health services, and this could influence the results in adults. In very young children, it seems unlikely that there are behavioral differences between the sexes that could impact on the incidence rates for viral meningitis.

Sex differences in response to infections may be due to the imbalance in the expression of genes encoded on the X and Y-chromosomes of a host [@bb0140]. X chromosome associated biological processes and X-linked genes appear to be responsible for the immunological advantage of females due to the X-linked microRNAs related processes. It has been proposed that the phenomenon of X chromosome inheritance and expression is a cause of immune disadvantage of males and the enhanced survival of females following immunological challenges [@bb0140]. In females, two X chromosomes associate with plasmacytoid dendritic cells (pDCs) that are more activated and display a more anti-viral phenotype [@bb0055]. Actual sex-linked immunodeficiency seems to be too rare to explain the magnitude of the excess incidence rates observed in young males, but it may be partially explained by relative immunodeficiency in males [@bb0060].

Hormonal factors could be implicated. Females generally exhibit elevated humoral and cell-mediated immune responses to viral infections compared to males [@bb0020], [@bb0145], [@bb0150], [@bb0155]. The development and activity of both innate and adaptive immunity can be mediated through estrogen, androgen, and progesterone receptors [@bb0160]. Estradiol enhances production of pro-inflammatory cytokines and chemokines in response to TLR ligand stimulation of dendritic cells and macrophages, which could contribute to the superior immune response to viral infection often observed in females [@bb0150], [@bb0155]. Whereas estrogens are associated with proliferation and differentiation of lymphocytes and monocytes, androgens suppress the activity of immune cells by increasing the synthesis of anti-inflammatory cytokines [@bb0165], [@bb0170]. Progesterone regulates the development of myeloid cells and dendritic cells to promote immune tolerance [@bb0175], [@bb0180]. Some studies have demonstrated that progesterone modifies the activity of the T cell population, suppresses the type I interferon producing Th1cells and favors the IL-10 producing Th2 type cells [@bb0180].

In children, in highly-vaccinated populations such as in the current study, the most common cause of viral meningitis is usually enteroviruses, such as coxsackie, ECHO and enterovirus 71 [@bb0025], [@bb0030], [@bb0035], [@bb0040], [@bb0185]. The first line of defense is mediated through the innate immune system, with type I interferon (IFN) initialization at the first stage and subsequently induction of the expression of IFN-stimulated genes that lead to destruction of viruses [@bb0190]. In the adaptive response, following enterovirus infection, T cells play a critical role in infiltration of CD4 + and CD8 + lymphocytes within the central nervous system. Both innate and adaptive immune responses differ between males and females. Estradiol promotes innate immune signaling pathways, including macrophages, dendritic cells (DCs), granulocytes, and lymphocytes cell development and the production of type I interferon [@bb0195], the key factor in the immune response against viral infections. Female pDCs produce more type I IFN than male pDCs [@bb0200]. Progesterone inhibits the immune response to viruses via IFN-alpha production downregulation by pDCs and providing a potential explanation for innate antiviral immunity modulation in women [@bb0205].

In infancy, the transient rise in sex steroid levels ('minipuberty') could affect immune cells differently in boys and girls [@bb0210]. During this period of life, there is a post-natal hypothalamic--pituitary-gonadal surge, characterized by an activation of gonadal hormones in both, boys and girls [@bb0210], [@bb0215]. Testosterone levels predominate in boys at 1--3 months of age and decline at 6--9 months of age, whereas in girls, estradiol high levels remain elevated longer. This phenomenon of "minipuberty" with high gonadal hormone levels is able to stimulate the target tissues in both sexes [@bb0210], [@bb0215], [@bb0220]. It is possible that the physiological and immune differences that occur in mini-puberty may be "carried over" from infancy into the early childhood. Courant F et al. [@bb0225] demonstrated significant sex differences in late childhood (pre-pubertal) sex hormone levels. Plasmacytoid dendritic cells from healthy females produced more type 1 IFN than males, even before puberty, but puberty itself associated with increased production of type 1 IFN [@bb0055]. This was related to X chromosome number, and serum testosterone concentration, in a manner which differed depending on the number of X chromosomes present [@bb0055]. Sex hormones and genetic factors (X chromosome number) were associated individually and interactively with the type I interferon response [@bb0055], which could contribute to our understanding of why young males exhibit higher viral meningitis incidence rates.

In the present study, during the female reproductive age, the dominance of overall male incidence rates is no longer evident. This may partly be due to behavioral differences and partly because of viral meningitis etiology. As we mentioned, in young adults, females may be more likely to be exposed to viruses when caring for sick children and in the workplace such as hospitals, schools and kindergartens. Young adult females may be more likely to be with enteroviruses during the care of children excreting the virus. It should be noted that HSV-2 is a cause of viral meningitis in adult females and males [@bb0230], [@bb0235], [@bb0240], and is sexually transmitted. During middle adulthood, there is no significant overall differences in incidence rates between the sexes. With aging, there are profound changes in the immune and endocrine systems, reducing the sex differences in the susceptibility to infectious diseases [@bb0245].

4.1. Strengths and limitations of the study {#s0110}
-------------------------------------------

This study has several strengths and limitations. One of the main strengths is that the study was based on national data with very large populations and consequently large numbers of cases. Selection bias has been minimized by using national data over different time periods, which should be representative of each country. The inclusion of five countries, each evaluated over a number of years, allowed us to evaluate the consistency of the findings over different populations and different time periods. As regards the potential for information bias, there does not appear to be any reason to believe that the reporting of viral meningitis in infants and children is different for males and females. The countries examined do not have a culture of giving preferable treatment to males, although in adults, there could be differences between males and females in the utilization of medical care. Although the surveillance and methods for the diagnosis of viral meningitis may not be identical over countries and time, it does not seem likely that this will differ between males and females. Any misdiagnosis is unlikely to be different in males and females and is likely to be non-differential. Thus, if anything, the excess incidence rates in males in infants and children may be higher than we found.

5. Conclusions {#s0115}
==============

This study has demonstrated excess incidence rates from viral meningitis in male infants and children, which is remarkably consistent over different countries and time periods. This suggests that the finding is unlikely to be due entirely to behavioral differences between males and females, particularly in infancy. The mechanism underlying the excess incidence rates remains largely unexplained. The importance of evaluating sex differences in disease is an increasing area of interest in the understanding of the mechanisms of disease. Our findings should stimulate investigations on sex-related factors impacting on the clinical manifestation of viral meningitis and help in the development of new vaccines.

Appendix A. Supplementary data {#s0140}
==============================

Supplementary materialImage 1
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